After the epidemic, the hottest thing is China’s medical and health industry. From national policy to the call of people’s livelihood, China’s big health industry must be upgraded. Everyone believes that the big health industry will usher in a period of strategic opportunity. It is especially manifested in Internet medical treatment, medical big data and AI-assisted diagnosis, and innovative drugs. However, opportunities and challenges often coexist. After the epidemic, the industry will definitely have a big development, but for companies that are not fast enough or strong enough, it is better to say that it is a major crisis.

文 | 商 学院

Abstract | After the epidemic, the hottest thing is China’s medical and health industry. From national policy to the call of people’s livelihood, China’s big health industry must be upgraded. Everyone believes that the big health industry will usher in a period of strategic opportunity. It is especially manifested in Internet medical treatment, medical big data and AI-assisted diagnosis, and innovative drugs. However, opportunities and challenges often coexist. After the epidemic, the industry will definitely have a big development, but for companies that are not fast enough or strong enough, it is better to say that it is a major crisis.

Then, what challenges will companies in various fields of big health face?

1. Internet medical treatment

Internet medical has been a fire with the help of mobile Internet, but the profit model is not clear so far, and everyone is familiar with online registration. Mobile medical care does not fundamentally solve the core problems of the ugly and expensive medical treatment of patients, and its value to hospitals and doctors is also relatively limited. What are the attributes of the Internet? Information interaction, high-frequency interaction, and data collection. If you cannot empower medical care from these characteristics, it is difficult to see the ability to sustain the platform’s valuation and capital investment.

2. Medical big data and AI-assisted diagnosis

In this epidemic, the use of clinical evidence from CT images to confirm the diagnosis of new coronary pneumonia is a breakthrough change, which also validates the value of intelligent image recognition products. However, what is truly recognized in the clinic is still “unicorns” with equipment manufacturing background, early completion of a large amount of clinical accumulation, and rich training data, rather than the collective “normalization” of the entire industry. After the epidemic, “unicorns” will rise and competition in the entire market will increase. Without in-depth participation of clinical experts, companies without training data will have to pay higher prices and pay more tuition fees.

3, innovative medicines

Many people think that the policy and capital investment of new drug research and development after the epidemic will definitely be stronger. It should be noted that in the face of the major interests of national health, regardless of national boundaries, the effective one wins. Accelerated approval of new drugs is likely to make innovations strong, and more accumulated overseas players have directly entered the novice village. Secondly, a major feature of domestic new drug development is homogeneity. A new vocabulary like PD-1 / PD-L1 has created a new term, the typical “highRepeated construction of levels “. I really want to do a good job in the development of new drugs, either to be the niche disease No. 1, or the 1st class of similar drugs; simply follow on, high-tech brick-and-roll mode, it is difficult to continue.

Entrepreneurship in the medical and health industry is not a Marvel superhero movie. A single shot can save the world. It is a play on “Wandering Earth” without the support of various teams. Isn’t the actual version of “Super Saturated Rescue” the whole process of fighting the epidemic?

So, in the end, how should medical and health enterprises seize the window opportunity to achieve overtaking in the corner after this epidemic?

Together with a team of domestic top academicians and experts, start the star training program for the large health industry, and extensively recruit companies with innovative capabilities and willingness to upgrade in the medical and health industry to find potential industry stars.

By then, companies can have in-depth docking and communication with the country’s top medical and health research institutes, well-known academicians and expert teams, specialized medical institutions, front-line investors, and industry leaders’ executives. , Capital, channels and other enterprise core needs. Help enterprises outperform their sub-sectors and become industry stars.

Upgrade or phase out? A new pattern will emerge after the health industry epidemic I. Top industry resource links are the core

In the field of medical and health care in our country, the current industry level lags behind the scientific research level. Then, the core point of improving the competitiveness of domestic large health industry companies is to combine top scientific research results with industry, and connect industrial results with the medical system.

Research bottlenecks helped by scientific research institutes

5+ national top scientific research institutes visit, core experts of scientific research institutions will share with you privately, leading everyone to understand the most cutting-edge innovations in the field of health, helping everyone find the direction of innovation and more opportunities for docking and cooperation. Standing on the shoulders of the country’s top innovation achievements, it is possible to obtain industrial breakthrough development.

Research resources of academicians and experts

This plan connects more than 20+ academicians and industry expert mentors. Expert mentors also need to translate their scientific research achievements to the ground. During the sharing and exchange process, they have the opportunity to establish deep connections with expert mentors, such as jointly setting up horizontal projects. Promote the level of scientific research and innovation of enterprises, and at the same time enhance the professional value of medical products or services.

Fully open access to medical institutions

The outstanding companies in the plan will be comprehensiveOpen sales channels to medical institutions-outstanding products will be endorsed by experts and recommended to more than 100 “health promotion pilot hospitals”. Functional foods and wearable devices have the opportunity to enter health promotion pilot hospitals and join their non-drug health management product series; health care real estate and medical service companies have the opportunity to combine hospital experts with multiple practices to build a health management ecology outside the hospital; medical treatment There is a huge opportunity for healthy big data and artificial intelligence companies to establish scientific research pilots and integrate mining data.

Precise docking of front-line investment institutions

This plan invites top20 investment institutions in the medical and health sector to participate in depth and communicate behind closed doors. Not only can companies learn to review and plan their operations from the perspective of investors, they can also help investment institutions and companies to accurately match and establish deep links to maximize financing efficiency. In addition to each offline link, all student companies will continue to enjoy the close attention of a large number of well-known investment institutions.

Upgrade or phase out? A new pattern will emerge in the medical and health industry after epidemic Second, expert mentor group advisory counseling to assist in solving key decision-making problems of enterprises

How should we interpret the relevant policies of China’s health care industry? How to plan the next 5-year strategy? How to quickly innovate and compete with the market in homogeneous competition? All are tortured by the soul of medical and health companies. This program brings together a luxury mentor group composed of industry experts and academicians, life science and medical clinical experts, executives of major health industry leaders, and investors from frontline institutions of the big health track to help trainees clarify policies and see the direction. Lead the companies in the plan to discuss in depth how the connected scientific research results can be combined with their respective companies to form an industrialization plan. The technology, products and commercialization channels of the big health industry have distinctive industry characteristics, so we provide sufficient docking scenarios to allow expert mentor groups to help companies locate and analyze existing products or services, so that each student can get personalized guidance , Optimize and enhance the product experience and enhance the overall strength.

Upgrade or phase out? New pattern will emerge in the medical and health industry after epidemic

Third, horizontal connection,It ’s the integration of resources, but also the mutual encouragement on the road of entrepreneurship

Each time we connect offline, we will provide ample opportunities for companies to horizontally display and communicate. Perhaps, your classmates will be your important industrial partners in the future. Before a career is successful, it is not questioned and frustrated. This journey may only be understood by those with you. Not only can excellent companies collide with each other, they can also support and inspire each other! Strength and mental strength are essential for success. Maybe you can get it in the “Big Health Industry Star Training Program” of the business school.

Upgrade or phase out? A new pattern will emerge after the health industry epidemic

Fourth, plan setting details

-The project cycle is one year, including 4 times of industry learning, 4 times of industrial resource docking

-Enjoy year-round incubation services, connect capital, scientific research resources, medical institution resources, media resources from time to time

-Excellent projects will also receive academician face-to-face defense opportunities, opportunities to set up topics with well-known experts in the industry, opportunities to initiate clinical pre-research projects with scientific and clinical experts, and participate in regional key hospital medical gatherings.

Upgrade or phase out? A new pattern will emerge after the medical industry epidemic

If you are an entrepreneur seeking innovation in the medical and health industry, want to link more scientific research resources, open up market access, find a clear direction, and solve business confusion, please contact us through the following methods. Perhaps, the level of China’s big health industry will be enhanced by our efforts.

You can scan the code now and join us

Please contact us for more details: Mr. Kong 13581925334 (WeChat / Phone)

upgrade orEliminated?  A new pattern will emerge in the medical and health industry after epidemic